Effect of ketorolac Spray on Reducing Pain in Patients with mandible Fractures

Comparison of Analgesic Efficacy of intravenous and intranasal ketorolac in patients undergoing mandibular fracture surgery

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150628022951N8

Enrollment

Registered

2018-09-14

Start date

2018-09-22

Completion date

Unknown

Last updated

2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain. Acute pain due to trauma

Interventions

Intervention 1: Intervention group: Intravenous injection of 30 mg ketorolac ampoule every 8 hours. Intervention 2: Intervention group: Intranasal 15% ketorolac spray every 6 hours.

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with unilateral fracture of mandible in body and angle region, Which has not been fractured for more than 3 months

Exclusion criteria

Exclusion criteria: Addicted patients

Design outcomes

Primary

Measure	Time frame
Pain Intensity. Timepoint: 2, 4, 6, 8, 12, 24, 36 and 48 hours after surgery. Method of measurement: Visual Analogue Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactJavad Yazdani

Tabriz University of Medical Sciences

Ja_yazdani@yahoo.com+98 41 3336 4658

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026